Dr. Mazyar Shadman is a blood cancer specialist who focuses on lymphoid malignancies. He is involved in clinical research using novel therapeutic agents for lymphoma and chronic lymphocytic leukemia (CLL), as well as immunotherapy (specifically CAR T-cell therapy) for lymphoid neoplasms and blood stem cell transplant for hematologic malignancies. His goal is to identify the best treatment sequence or combination for patients with high-risk lymphoma and CLL.
Current research topics include:
Therapeutic clinical trials in lymphoid malignancies with a focus on CLL/SLL
CAR T-cell therapy for lymphoma/CLL
Clinical outcome research in lymphoid malignancies
